Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

6 Search results.

Baseline MRI Visit 08 SirTac NCT02936388 - Baseline MRI Visit 08

- 11/26/17 - 1 form, 3 itemgroups, 20 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Visit 06 SirTac NCT02936388 - Baseline MRI Visit 06

- 11/26/17 - 1 form, 3 itemgroups, 20 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI 12- Weeks Visits SirTac NCT02936388 - Baseline MRI 12- Weeks Visits

- 12/3/17 - 1 form, 3 itemgroups, 20 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI 6- Weeks Visits SirTac NCT02936388 - Baseline MRI 6- Weeks Visits

- 12/3/17 - 1 form, 3 itemgroups, 20 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Screening Day -14 to 0 SirTac NCT02936388 - Baseline MRI Screening Day -14 to 0

- 11/26/17 - 1 form, 3 itemgroups, 13 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Baseline MRI Screening Day -14 to 0 SirTac NCT02936388 - Baseline MRI Screening Day -14 to 0

- 11/20/17 - 1 form, 3 itemgroups, 13 items, 1 language

Itemgroups: Baseline MRI, location liver, Non-target Lesions

Study part: Baseline MRI Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.